Category: News

Posted on

Change in NIH Application Resubmission Policy

by
8 comments

NIH has just announced a significant change in its policy for resubmission applications.

Effective immediately, for application due dates after April 16, 2014, following an unsuccessful resubmission (A1) application, applicants may submit the same idea as a new (A0) application for the next appropriate due date. NIH will not assess the similarity of the science in the new (A0) application to any previously reviewed submission when accepting an application for review.

NIH’s policy for accepting overlapping applications remains in effect (see NOT-OD-09-100), so it will not accept duplicate or highly overlapping applications under review at the same time. This means that NIH will not review:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).

The NIH time limit for accepting resubmission (A1) applications remains in effect, as well (see NOT-OD-12-128 and NOT-OD-10-140). NIH will not accept a resubmission (A1) application that is submitted later than 37 months after submission of the new (A0) application that it follows.

Also remaining in effect is the NIH policy for new investigator R01 resubmission deadlines, described in NOT-OD-11-057.

Background and details on the new resubmission policy are in NIH Guide NOT-OD-14-074 and a blog post by NIH’s Sally Rockey.

Posted on

Give Input on Structural Biology Resource and Infrastructure Needs

by
1 comment

Earlier this year, I told you about the formation of two committees focused on Protein Structure Initiative (PSI) transition planning. These committees are charged with determining what unique resources and capabilities developed during the PSI should be preserved after the initiative ends and how this preservation should be done.

An important part of this process is getting input from the community, so we have just issued a request for information (RFI), NOT-GM-14-115, seeking comments about structural biology resources that have a high impact on the community, whether those resources have been supported through the PSI or by other means. We also want to hear what you think about the future of structural biology-related technology development, which has been an important feature of the PSI.

While the RFI invites comments on these specific topics, you should not feel limited to them—we welcome any comments that you feel are relevant.

To respond to the RFI, send an e-mail to nigmspsirfi@mail.nih.gov by May 23, 2014. When we compile the responses, we’ll remove any personal identifiers like names and e-mail addresses and only use de-identified comments.

If you have any questions about the RFI or the transition committees, please let me know.

Posted on

Protein Structure Initiative Transition Planning Committees

by
0 comments

Shortly after NIGMS Director Jon Lorsch announced plans to sunset the Protein Structure Initiative after the completion of the PSI:Biology phase in 2015, he commissioned two committees to determine what unique resources and capabilities developed during the PSI should be preserved and how that should be done. The committees, which are working together, held their first meetings in December and expect to present their recommendations within the year.

The external committee, which includes practitioners of structural biology and biomedical researchers who use structural biology data and resources in their work, will primarily focus on community needs. It also will suggest emerging challenges and opportunities in structural biology.

The internal committee, which is composed of NIH staff, will focus on how to implement the priorities identified by the external committee. The group includes a member from each NIGMS scientific division as well as several representatives from other NIH institutes who have experience managing structural biology and large, complex research programs.

The work of these committees will help define how we can provide continued access to important structural biology resources and identify new directions for technology development with potential for broad biomedical impact.

As Jon wrote in a Feedback Loop post about bolstering support for investigator-initiated research and as also reported in a Nature news article, the decision to sunset a large set-aside program that has received substantial investments, such as the PSI, should not be interpreted as a lack of support for team science. Multidisciplinary collaborations are likely to become increasingly important as we delve deeper into complex biological problems, and we will continue to sponsor team approaches to biomedical research. We also remain committed to supporting structural biology research through investigator-initiated grant mechanisms, innovative technology development and access to critical resources.

Posted on

Give Input on Training Activities Relevant to Data Reproducibility

by
2 comments

Data reproducibility is getting a lot of attention in the scientific community, and NIH is among those seeking to address the issue. At NIGMS, one area we’re focusing on is the needs and opportunities for training in areas relevant to improving data reproducibility in biomedical research. We just issued a request for information to gather input on activities that already exist or are planned as well as on crucial needs that an NIGMS program should address.

I strongly encourage you and your colleagues to submit comments by the February 28 deadline (no longer available). The information will assist us in shaping a program of small grants to support the design and development of exportable training modules tailored for graduate students, postdoctoral students and beginning investigators.

UPDATE: NIGMS and additional NIH components have issued the Training Modules to Enhance Data Reproducibility (R25) funding opportunity announcement. The application deadline is November 20.

Posted on

NIGMS Training, Workforce Development, and Diversity Division Director Clif Poodry Retires

by
23 comments

Clifton Poodry, Ph.D.Clifton “Clif” Poodry, Ph.D., director of the NIGMS Division of Training, Workforce Development, and Diversity, retired earlier this month. Although he’s left federal service, Clif is continuing to pursue his long-held interest in improving science education as a senior fellow at the Howard Hughes Medical Institute.

Throughout his nearly 20 years at NIGMS, Clif championed—and in many cases, led—activities to build the biomedical research workforce of the future. This included initiatives for training and mentoring students from groups that are underrepresented in biomedical and behavioral research and advising on NIH-wide programs, such as the newly announced Building Infrastructure Leading to Diversity program.

Clif has long been committed to using scientific approaches to understand interventions that promote interest in and pursuit of research careers. He consistently encouraged staff and colleagues to read the scientific literature on training and workforce diversity in order to develop a better understanding of biomedical workforce issues and challenges so that we could create and/or modify programs accordingly.

Clif’s long and distinguished career includes time as a biology professor, department chair, associate vice-chancellor for student affairs, and NIGMS grantee at the University of California, Santa Cruz. In the early 1980s, he served a 2-year stint at the National Science Foundation, where he helped create a program that later became a model for the NIH diversity supplement program.

Clif is a great and natural mentor who has touched the lives of numerous students and colleagues across the country, as well as those of us here at NIGMS and NIH. Many of those he mentored have gone on to positions in academia, government and the private sector.

Clif has had a huge impact in many areas, including the education and training of students from underrepresented groups, and we look forward to building on his legacy.

Posted on

Judith Greenberg Named Acting Deputy Director of NIGMS

by
0 comments

Photo of Dr. Judith GreenbergI am pleased to tell you that Judith Greenberg has agreed to serve as acting deputy director of NIGMS while a search for a permanent deputy director takes place. A news announcement on her appointment is posted at http://www.nigms.nih.gov/News/Results/pages/
20131024a.aspx.

As most of you know, Judith has served in numerous leadership roles at NIGMS and NIH, including two stints as NIGMS acting director.

In her new role, Judith will provide advice and expertise on all Institute activities. She will also continue to serve as director of the Division of Genetics and Developmental Biology, a position she has held since 1988.

Once the job announcement for a permanent deputy director is posted, I will be sure to alert you via this blog.

Posted on

Resumption of NIH Extramural Activities

by
1 comment

One of the biggest challenges facing NIH after the government shutdown is that it occurred during a peak review period and caused the cancellation of several hundred peer review meetings. On October 22, NIH announced that most of these meetings would be rescheduled so as to minimize the disruption of the submission/review/Council/award timeline.

While NIH may not be able to preserve the timeline for all applications, at this point, it looks as though most will still go to January 2014 council meetings. More details are available in a new NIH Guide notice.

Most of the study sections run by the NIGMS Office of Scientific Review were not affected by the shutdown and will proceed as planned over the next few weeks. While a few meetings will have to be rescheduled, we expect the results of the rescheduled meetings to be available in time for our January council meeting.

The other big challenge facing NIH and the extramural community is the disruption in the application process, since funding opportunity announcements (FOAs) could not be accessed and applications could not be submitted during the shutdown. NIH has rescheduled the submission dates that were lost and extended the dates for those FOAs that were adversely affected. More details are available in the same NIH Guide notice.

Sally Rockey’s blog provides more on NIH’s efforts to minimize the disruption of the shutdown’s effects on the extramural community.

Posted on

Enabling Science through Data (Big and Otherwise)

by
1 comment

NIH’s recent focus on data-intensive and data-driven biomedical research makes this an exciting time for me to be joining NIGMS and leading its Division of Biomedical Technology, Bioinformatics, and Computational Biology (BBCB).

New steps toward harnessing the power of data began well before my arrival and include the NIH Big Data to Knowledge (BD2K) initiative. The overarching aim of this initiative is to enable, by the end of this decade, a “quantum leap” in the ability of the biomedical and behavioral research enterprise to use the growing volume of complex data to produce important insights into biological systems. This is an ambitious goal that requires the collective engagement and expertise of NIH’s many institutes, centers, and offices, including NIGMS, as well as the scientific community.

My colleagues from across NIH have already come together to discuss future solutions that will benefit NIH and the research community as a whole. We recognize that no one-size-fits-all solution will emerge as the “data quantum leap.” Our hope is that by engaging academic, industrial and other biomedical stakeholders, we will impact the volume, variety, velocity, viability and ultimately value of the data that NIH invests in.

To jumpstart this activity, NIH recently issued a new funding opportunity announcement (FOA) for Centers of Excellence for Big Data Computing in the Biomedical Sciences. The purpose is to establish an interactive consortium of centers that will develop approaches, methods and software tools for the aggregation, integration, analysis and visualization of data across NIH-funded research areas. NIH also has issued a request for information on the development of analysis methods and software for big data; responses are due by September 6.

NIGMS and the BBCB staff were actively involved in crafting the new FOA and, more generally, have played a central role in the creation and organization of the BD2K initiative. We will continue to be active partners in this endeavor.

Big data is just one example of the division’s efforts. We foster research in a range of fields, including computational biology, bioinformatics, mathematical and statistical biology, and biomedical technology development. We also support programs that train people in many of these areas.

I’m so happy to be involved in shaping the division’s activities, and I look forward to working together with many of you to continue innovating basic biomedical research.

Posted on

Advancing Emergency Care Research

by
1 comment

I’m the director of the newly created NIH Office of Emergency Care Research (OECR), which is housed in NIGMS. For the past 11 years, I was an emergency medicine physician and clinical researcher. So you might be wondering why I’m writing a post for a blog primarily read by thousands of basic scientists. Don’t stop reading, though, because OECR and NIGMS-funded research have more in common than you might think. Let’s take a quick look at one area where basic and emergency medicine research interests converge—sepsis.

NIGMS supports both fundamental studies and clinical research on sepsis, including the PRoCESS (Protocolized Care for Early Septic Shock) clinical trial. This study is designed to determine if early intervention with rigorous, standardized care in sepsis and septic shock can improve clinical outcomes. It’s an astonishingly important effort to address a disease that often presents to the emergency department and that has a mortality rate of about 30 percent. Should the study demonstrate improved outcomes, it will change the care of some 750,000 Americans who develop sepsis each year.

In addition to sepsis, NIGMS funds research in other areas relevant to emergency medicine, including trauma, burn injury, wound healing, and anesthesia.

I’m committed to helping all parts of NIH improve outcomes for patients in need of emergency treatment, and stepping into the OECR position is allowing me to focus on the national challenges that face emergency medicine research. Toward this end, OECR has four objectives:

  • To develop and refine NIH’s existing research portfolios in emergency care;
  • To coordinate research projects that involve multiple NIH components;
  • To create ways to fund new research that impacts patients with time-sensitive medical conditions; and
  • To promote the training of the next generation of emergency care researchers.

It’s a big mission for a small office, but we are fortunate to have many energetic partners across NIGMS, NIH and the broader community.

Whether you’re a basic scientist or a clinician, the ultimate goals are the same, so I welcome your interest in and input on OECR activities.

Posted on

Susan Gregurick Joins NIGMS as Director of Biocomputing and Technology Division

by
0 comments

I’m pleased to introduce you to Susan Gregurick, the new director of our Division of Biomedical Technology, Bioinformatics, and Computational Biology (BBCB).

This is a particularly exciting time for the division, which funds research and training that join biology with the computer sciences, engineering, mathematics and physics. Its activities include supporting research centers in biomedical technology and systems biology as well as computational models of the spread of infectious diseases and the potential effects of interventions. The division also leads the NIH Biomedical Information Science and Technology Initiative and collaborates with the National Science Foundation to support programs in mathematical biology.

A leader in computational biology and bioinformatics with experience in government and academia, Dr. Gregurick brings the expertise and vision needed to help shape this relatively new division and advance its mission. Please join me in welcoming her to NIGMS.